Autor: "Signorovitch JE" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome
Autorzy:: Chen KS
Xie J
Tang W
Zhao J
Jeppesen PB
Signorovitch JE; Pokaż więcej
Temat:: short bowel syndrome
intestinal failure
teduglutide
subpopulation
Therapeutics. Pharmacology
RM1-950
Źródło:: Therapeutics and Clinical Risk Management, Vol Volume 14, Pp 1267-1277 (2018)
Opis pliku:: electronic resource
Relacje:: https://www.dovepress.com/identifying-a-subpopulation-with-higher-likelihoods-of-early-response--peer-reviewed-article-TCRM; https://doaj.org/toc/1178-203X
Dostęp URL:: https://doaj.org/article/646881e542fe4c4a82e1159902f669aa Link otwiera się w nowym oknie

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis
Autorzy:: Donohue JF
Betts KA
Du EX
Altman P
Goyal P
Keininger DL
Gruenberger JB
Signorovitch JE; Pokaż więcej
Temat:: COPD
long-acting β2-agonists
network meta-analysis
systematic literature review
indacaterol
Diseases of the respiratory system
RC705-779
Źródło:: International Journal of COPD, Vol Volume 12, Pp 367-381 (2017)
Opis pliku:: electronic resource
Relacje:: https://www.dovepress.com/comparative-efficacy-of-long-acting-beta2-agonists-as-monotherapy-for--peer-reviewed-article-COPD; https://doaj.org/toc/1178-2005
Dostęp URL:: https://doaj.org/article/83b091428ec14721811556ae6700bb15 Link otwiera się w nowym oknie

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: PND5 - Deflazacort or Prednisone Treatment for Duchenne Muscular Dystrophy: A Meta-Analysis of Disease Progression Rates in Recent Multicenter Clinical Trials
Autorzy:: Signorovitch, JE
Sajeev, G
McDonnell, E
Yao, Z; Pokaż więcej
Źródło:: In Value in Health October-November 2017 20(9):A718-A718

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 4.

Tytuł:: PRS3 - Feasibility of Matching-Adjusted Indirect Comparison (MAIC) of Omalizumab (OMA) vs. Mepolizumab (Mepo) in Moderate-to-Severe Asthma
Autorzy:: Ayyagari, R
Álvares, L
Mu, F
Hacking, V
Martinez, R
Signorovitch, JE; Pokaż więcej
Źródło:: In Value in Health November 2016 19(7):A549-A549

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 5.

Tytuł:: Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept.
Autorzy:: Signorovitch JE (AUTHOR)
Wu EQ (AUTHOR)
Yu AP (AUTHOR)
Gerrits CM (AUTHOR)
Kantor E (AUTHOR)
Bao Y (AUTHOR)
Gupta SR (AUTHOR)
Mulani PM (AUTHOR)
Signorovitch, James E (AUTHOR)
Wu, Eric Q (AUTHOR)
Yu, Andrew P (AUTHOR)
Gerrits, Charles M (AUTHOR)
Kantor, Evan (AUTHOR)
Bao, Yanjun (AUTHOR)
Gupta, Shiraz R (AUTHOR)
Mulani, Parvez M (AUTHOR); Pokaż więcej
Źródło:: PharmacoEconomics. 2010, Vol. 28 Issue 10, p935-945. 11p.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 6.

Tytuł:: PIN5 - Daclatasvir +Asunaprevir Versus Sofosbuvir/Ledipasvir for The Treatment of Chronic Hepatitis C Genotype 1 In Japanese Patients: A Matching-Adjusted Indirect Comparison
Autorzy:: Swallow, E
Kelley, C
Ristovska, L
Signorovitch, JE
Kalsekar, A
Wygant, G
McPhee, F; Pokaż więcej
Źródło:: In Value in Health November 2015 18(7):A576-A576

na półce

Szczegóły

Skocz do pozycji: 7.

Tytuł:: PSY2 - Clinical and Economic Burden of Pulmonary Excerbations In Patients With Cystic Fibrosis Who are Homozygous For The F508del Mutation
Autorzy:: O’Sullivan, AK
Signorovitch, JE
Fang, A
Wagener, J
Hodgkins, P; Pokaż więcej
Źródło:: In Value in Health November 2015 18(7):A658-A659

na półce

Szczegóły

Skocz do pozycji: 8.

Tytuł:: Clinical and Economic Burden of Pulmonary Excerbations In Patients With Cystic Fibrosis Who are Homozygous For The F508del Mutation.
Autorzy:: O’Sullivan, AK
Signorovitch, JE
Fang, A
Wagener, J
Hodgkins, P
O'Sullivan, A K (AUTHOR)
Signorovitch, J E (AUTHOR); Pokaż więcej
Źródło:: Value in Health. Nov2015, Vol. 18 Issue 7, pA658-A659. 1p.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 9.

Tytuł:: Daclatasvir +Asunaprevir Versus Sofosbuvir/Ledipasvir for The Treatment of Chronic Hepatitis C Genotype 1 In Japanese Patients: A Matching-Adjusted Indirect Comparison.
Autorzy:: Swallow, E
Kelley, C
Ristovska, L
Signorovitch, JE
Kalsekar, A
Wygant, G
McPhee, F
Signorovitch, J E (AUTHOR); Pokaż więcej
Źródło:: Value in Health. Nov2015, Vol. 18 Issue 7, pA576-A576. 1p.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 10.

Tytuł:: Effectiveness of first-line treatments in metastatic squamous non-small-cell lung cancer.
Autorzy:: Levy BP; Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, Washington, DC.
Signorovitch JE; Analysis Group, Inc., Boston, MA.
Yang H; Analysis Group, Inc., Boston, MA.
Patterson-Lomba O; Analysis Group, Inc., Boston, MA.
Xiang CQ; Analysis Group, Inc., Boston, MA.
Parisi M; Celgene Corporation, Summit, NJ, U.S.A.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2019 Jun; Vol. 26 (3), pp. e300-e308. Date of Electronic Publication: 2019 Jun 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Albumins/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carboplatin/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Carcinoma, Squamous Cell/*drug therapy
Deoxycytidine/*analogs & derivatives
Lung Neoplasms/*drug therapy
Paclitaxel/*therapeutic use
Aged ; Antineoplastic Agents/therapeutic use ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Deoxycytidine/therapeutic use ; Female ; Humans ; Immunotherapy ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Survival Analysis ; Treatment Outcome ; Gemcitabine

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA.
Autorzy:: Pal SK; City of Hope Comprehensive Cancer Center, Duarte, California, USA.
Signorovitch JE; Analysis Group, Boston, Massachusetts, USA.
Li N; Analysis Group, Boston, Massachusetts, USA.
Zichlin ML; Analysis Group, Boston, Massachusetts, USA.
Liu Z; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Ghate SR; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Perez JR; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Vogelzang NJ; US Oncology Research, Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, USA.; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2017 Apr; Vol. 24 (4), pp. 272-278. Date of Electronic Publication: 2017 Mar 02.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Antineoplastic Agents/*therapeutic use
Carcinoma, Renal Cell/*therapy
Kidney Neoplasms/*therapy
Practice Patterns, Physicians'/*statistics & numerical data
Protein Kinase Inhibitors/*therapeutic use
Aged ; Antineoplastic Agents/pharmacology ; Axitinib/pharmacology ; Axitinib/therapeutic use ; Carcinoma, Renal Cell/pathology ; Disease Progression ; Drug Resistance, Neoplasm ; Everolimus/pharmacology ; Everolimus/therapeutic use ; Female ; Humans ; Indazoles ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Molecular Targeted Therapy/methods ; Molecular Targeted Therapy/standards ; Molecular Targeted Therapy/statistics & numerical data ; Nephrectomy ; Practice Guidelines as Topic ; Protein Kinase Inhibitors/pharmacology ; Pyrimidines/pharmacology ; Pyrimidines/therapeutic use ; Retrospective Studies ; Sulfonamides/pharmacology ; Sulfonamides/therapeutic use ; Sunitinib/pharmacology ; Sunitinib/therapeutic use ; TOR Serine-Threonine Kinases/antagonists & inhibitors ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician survey.
Autorzy:: Lin PL; Analysis Group, Inc., Boston, Massachusetts.
Hao Y; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
Xie J; Analysis Group, Inc., New York, New York.
Li N; Analysis Group, Inc., Boston, Massachusetts.
Zhong Y; Analysis Group, Inc., Boston, Massachusetts.
Zhou Z; Analysis Group, Inc., Boston, Massachusetts.
Signorovitch JE; Analysis Group, Inc., Boston, Massachusetts.
Wu EQ; Analysis Group, Inc., Boston, Massachusetts.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2016 Feb; Vol. 5 (2), pp. 209-20. Date of Electronic Publication: 2015 Dec 21.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Physicians*
Practice Patterns, Physicians'*
Breast Neoplasms/*metabolism
Breast Neoplasms/*therapy
Receptor, ErbB-2/*metabolism
Receptors, Estrogen/*metabolism
Receptors, Progesterone/*metabolism
Breast Neoplasms/epidemiology ; Breast Neoplasms/pathology ; Drug Prescriptions ; Female ; Humans ; Male ; Neoplasm Metastasis ; Neoplasm Staging ; Postmenopause ; Risk Factors ; Surveys and Questionnaires ; United States/epidemiology